Why the study?
Does treatment with sulfhydryl-containing agents (captopril or MPG) improve survival and reduce myocardial injury in a murine model of viral myocarditis?
Population
4-week-old BALB/c mice inoculated with encephalomyocarditis virus.
Comparison
Captopril or N,2-mercapto-propionyl glycine once… vs Infected control mice given 0.1 ml of a glucose…
Design
Preclinical, Randomized on day 4, Histological examination performed by two…
Follow-up
14 days
Authors
Loading...
Hypothesis-generating for sulfhydryl agents in viral myocarditis; prospective human trials needed before clinical adoption.
Does treatment with sulfhydryl-containing agents (captopril or MPG) improve survival and reduce myocardial injury in a murine model of viral myocarditis?
Sulfhydryl-containing compounds like captopril and MPG significantly improve survival and reduce myocardial injury in a murine model of viral myocarditis, likely by scavenging oxygen free radicals.
Suzuki et al. (1993) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: